| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.644 | 0.003 | 0.644 | Alpha-N-acetylglucosaminidase inhibitor | 0.164 0.047 CID_115260 | ||
| 0.581 | 0.022 | 0.581 | Aldehyde oxidase inhibitor | |||
| 0.563 | 0.012 | 0.563 | GABA C receptor rho-3 antagonist | |||
| 0.481 | 0.002 | 0.481 | Creatine kinase inhibitor | |||
| 0.489 | 0.039 | 0.489 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.436 | 0.004 | 0.436 | GABA C receptor agonist | 0.137 0.04 CID_115260 | ||
| 0.459 | 0.034 | 0.459 | 5 Hydroxytryptamine release stimulant | |||
| 0.414 | 0.019 | 0.726 | Peroxidase inhibitor | 0.726 0.003 CID_115260 | CID_115260 | |
| 0.393 | 0.004 | 0.393 | Ferrochelatase inhibitor | |||
| 0.394 | 0.009 | 0.394 | Tyrosine 3 hydroxylase inhibitor | 0.323 0.024 CID_115260 | ||
| 0.42 | 0.066 | 0.42 | 5 Hydroxytryptamine release inhibitor | |||
| 0.373 | 0.02 | 0.373 | 5 Hydroxytryptamine uptake stimulant | 0.228 0.107 CID_115260 | ||
| 0.355 | 0.004 | 0.355 | Alcohol oxidase inhibitor | |||
| 0.376 | 0.031 | 0.603 | Superoxide dismutase inhibitor | 0.603 0.007 CID_115260 | CID_115260 | |
| 0.365 | 0.041 | 0.365 | Calcium channel activator | |||
| 0.327 | 0.009 | 0.327 | UDP-glucose 4-epimerase inhibitor | |||
| 0.312 | 0.009 | 0.312 | Succinate dehydrogenase inhibitor | |||
| 0.293 | 0.005 | 0.293 | Triose-phosphate isomerase inhibitor | |||
| 0.288 | 0.005 | 0.288 | Porphobilinogen synthase inhibitor | |||
| 0.272 | 0.008 | 0.272 | Adenylate kinase inhibitor | 0.247 0.01 CID_115260 | ||
| 0.27 | 0.008 | 0.27 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.248 0.01 CID_115260 | ||
| 0.38 | 0.123 | 0.38 | Caspase 9 stimulant | |||
| 0.256 | 0.014 | 0.256 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.26 | 0.026 | 0.26 | Nitric-oxide synthase stimulant | |||
| 0.272 | 0.055 | 0.272 | DNA synthesis inhibitor | 0.255 0.063 CID_115260 | ||
| 0.305 | 0.088 | 0.305 | Cholesterol antagonist | |||
| 0.23 | 0.016 | 0.23 | GABA C receptor rho-2 antagonist | |||
| 0.224 | 0.019 | 0.224 | Cystathionine beta-synthase inhibitor | |||
| 0.213 | 0.01 | 0.213 | GABA C receptor antagonist | |||
| 0.203 | 0.005 | 0.203 | Biliverdin reductase inhibitor | |||
| 0.204 | 0.01 | 0.204 | NADH dehydrogenase inhibitor | |||
| 0.244 | 0.053 | 0.244 | RNA-directed DNA polymerase inhibitor | |||
| 0.193 | 0.006 | 0.193 | Acyl-CoA dehydrogenase inhibitor | 0.084 0.021 CID_115260 | ||
| 0.187 | 0.011 | 0.391 | Glutamate dehydrogenase inhibitor | 0.391 0.004 CID_115260 | CID_115260 | |
| 0.181 | 0.006 | 0.181 | Ca2+-transporting ATPase inhibitor | |||
| 0.299 | 0.124 | 0.719 | Histamine release inhibitor | 0.719 0.004 CID_115260 | CID_115260 | |
| 0.185 | 0.011 | 0.185 | GABA C receptor rho-1 antagonist | |||
| 0.203 | 0.029 | 0.203 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.204 | 0.029 | 0.204 | Arachidonic acid antagonist | |||
| 0.181 | 0.013 | 0.181 | Phosphofructokinase-1 inhibitor | 0.096 0.033 CID_115260 | ||
| 0.175 | 0.012 | 0.175 | DOPA decarboxylase inhibitor | |||
| 0.171 | 0.009 | 0.171 | Carbamoyl phosphate synthetase inhibitor | 0.158 0.01 CID_115260 | ||
| 0.205 | 0.049 | 0.205 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.166 | 0.014 | 0.166 | Electrolyte absorption antagonist | |||
| 0.177 | 0.027 | 0.808 | Aminopeptidase B inhibitor | 0.808 0.001 CID_115260 | CID_115260 | |
| 0.212 | 0.063 | 0.212 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.247 | 0.099 | 0.423 | Insulysin inhibitor | 0.423 0.019 CID_115260 | CID_115260 | |
| 0.176 | 0.029 | 0.177 | Adenylate cyclase stimulant | 0.177 0.028 CID_115260 | CID_115260 | |
| 0.262 | 0.122 | 0.262 | Vasodilator, coronary | |||
| 0.167 | 0.027 | 0.167 | 5 Hydroxytryptamine 3A agonist | |||
| 0.158 | 0.024 | 0.291 | Catalase inhibitor | 0.291 0.006 CID_115260 | CID_115260 | |
| 0.229 | 0.095 | 0.322 | Interleukin agonist | 0.322 0.038 CID_115260 | CID_115260 | |
| 0.168 | 0.035 | 0.168 | Cathepsin H inhibitor | 0.167 0.035 CID_115260 | ||
| 0.179 | 0.052 | 0.179 | Amylase inhibitor | |||
| 0.14 | 0.015 | 0.783 | Glutamate decarboxylase inhibitor | 0.783 0.002 CID_115260 | CID_115260 | |
| 0.138 | 0.015 | 0.273 | Aminopeptidase I inhibitor | 0.273 0.004 CID_115260 | CID_115260 | |
| 0.229 | 0.107 | 0.279 | Gastrin inhibitor | 0.279 0.049 CID_115260 | CID_115260 | |
| 0.149 | 0.031 | 0.149 | Carbonic anhydrase XV inhibitor | |||
| 0.127 | 0.01 | 0.127 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.147 | 0.033 | 0.147 | Photosensitizer | 0.105 0.08 CID_115260 | ||
| 0.196 | 0.081 | 0.196 | Neurotrophic factor enhancer | |||
| 0.127 | 0.014 | 0.127 | Argininosuccinate synthase inhibitor | 0.096 0.02 CID_115260 | ||
| 0.118 | 0.006 | 0.118 | Aconitate hydratase inhibitor | |||
| 0.128 | 0.018 | 0.128 | Purinergic P2X2 antagonist | |||
| 0.153 | 0.045 | 0.331 | Aldehyde dehydrogenase inhibitor | 0.331 0.009 CID_115260 | CID_115260 | |
| 0.12 | 0.013 | 0.12 | Glycine receptor agonist | |||
| 0.122 | 0.015 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.217 | 0.112 | 0.217 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.133 | 0.029 | 0.133 | Anabolic | 0.107 0.054 CID_115260 | ||
| 0.128 | 0.024 | 0.128 | Histamine N-methyltransferase inhibitor | |||
| 0.12 | 0.018 | 0.399 | Phenylalanine 4-hydroxylase inhibitor | 0.399 0.003 CID_115260 | CID_115260 | |
| 0.119 | 0.018 | 0.119 | Glycine receptor antagonist | |||
| 0.16 | 0.06 | 0.16 | CF transmembrane conductance regulator agonist | |||
| 0.132 | 0.031 | 0.132 | Prolactin inhibitor | |||
| 0.17 | 0.07 | 0.17 | ATPase inhibitor | |||
| 0.107 | 0.007 | 0.107 | Glutamate (mGluR7) antagonist | |||
| 0.138 | 0.04 | 0.341 | Mucolytic | 0.341 0.004 CID_115260 | CID_115260 | |
| 0.113 | 0.017 | 0.113 | D-Ala-D-Ala ligase inhibitor | |||
| 0.121 | 0.025 | 0.558 | Histidine decarboxylase inhibitor | 0.558 0.002 CID_115260 | CID_115260 | |
| 0.182 | 0.086 | 0.182 | Anesthetic general | |||
| 0.1 | 0.005 | 0.1 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.108 | 0.015 | 0.593 | Ornithine carbamoyltransferase inhibitor | 0.593 0.002 CID_115260 | CID_115260 | |
| 0.158 | 0.068 | 0.158 | Interferon gamma antagonist | |||
| 0.166 | 0.079 | 0.748 | Phospholipase C inhibitor | 0.748 0.002 CID_115260 | CID_115260 | |
| 0.113 | 0.027 | 0.113 | Glutamate release inhibitor | |||
| 0.092 | 0.006 | 0.092 | Fumarate hydratase inhibitor | |||
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | 0.079 0.025 CID_115260 | ||
| 0.106 | 0.023 | 0.106 | GABA aminotransferase inhibitor | |||
| 0.097 | 0.015 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.094 | 0.012 | 0.094 | Exportin-1 inhibitor | |||
| 0.111 | 0.03 | 0.111 | CYP2A6 inhibitor | |||
| 0.101 | 0.023 | 0.101 | Estrogen-related receptor beta agonist | |||
| 0.119 | 0.04 | 0.119 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.129 | 0.051 | 0.129 | Microtubule formation inhibitor | |||
| 0.096 | 0.018 | 0.096 | Purinergic P2X1 antagonist | |||
| 0.105 | 0.028 | 0.105 | Keratolytic | |||
| 0.085 | 0.009 | 0.085 | Alpha-mannosidase inhibitor | 0.051 0.042 CID_115260 | ||
| 0.145 | 0.071 | 0.145 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.094 | 0.021 | 0.094 | Vanilloid 4 agonist | |||
| 0.157 | 0.086 | 0.257 | Neurotensin receptor agonist | 0.257 0.02 CID_115260 | CID_115260 | |
| 0.141 | 0.072 | 0.141 | Heat shock protein 70 antagonist | 0.141 0.07 CID_115260 | ||
| 0.091 | 0.023 | 0.091 | MAP kinase kinase 7 inhibitor | |||
| 0.148 | 0.081 | 0.148 | Hexokinase inhibitor | |||
| 0.109 | 0.043 | 0.109 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.109 | 0.043 | 0.109 | Glutamate (mGluR7) agonist | 0.092 0.079 CID_115260 | ||
| 0.089 | 0.023 | 0.089 | Phospholipase D inhibitor | |||
| 0.076 | 0.013 | 0.076 | Dihydroorotate oxidase inhibitor | |||
| 0.132 | 0.069 | 0.132 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.073 | 0.01 | 0.073 | Mannosidase inhibitor | |||
| 0.117 | 0.054 | 0.117 | Acetylcholine release stimulant | |||
| 0.096 | 0.035 | 0.096 | Na+ K+ transporting ATPase inhibitor | |||
| 0.129 | 0.068 | 0.191 | Vanilloid 1 agonist | 0.191 0.014 CID_115260 | CID_115260 | |
| 0.069 | 0.009 | 0.069 | Dopamine D5 agonist | |||
| 0.065 | 0.005 | 0.065 | Kainate receptor agonist | 0.043 0.024 CID_115260 | ||
| 0.12 | 0.06 | 0.12 | Transcription factor STAT6 inhibitor | |||
| 0.105 | 0.047 | 0.117 | Alcohol dehydrogenase inhibitor | 0.117 0.037 CID_115260 | CID_115260 | |
| 0.164 | 0.109 | 0.164 | MAP kinase kinase 2 inhibitor | |||
| 0.071 | 0.016 | 0.071 | Ryanodine receptor antagonist | |||
| 0.063 | 0.009 | 0.063 | Guanylate cyclase inhibitor | |||
| 0.06 | 0.007 | 0.06 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.125 | 0.072 | 0.23 | Cyclooxygenase 3 inhibitor | 0.23 0.011 CID_115260 | CID_115260 | |
| 0.09 | 0.037 | 0.09 | CC chemokine 5 receptor agonist | |||
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | 0.05 0.011 CID_115260 | ||
| 0.085 | 0.033 | 0.085 | GABA B receptor agonist | |||
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | |||
| 0.133 | 0.082 | 0.199 | Cell wall synthesis inhibitor | 0.199 0.03 CID_115260 | CID_115260 | |
| 0.065 | 0.014 | 0.065 | Adenylate cyclase 1 inhibitor | |||
| 0.061 | 0.01 | 0.061 | Alpha 1d adrenoreceptor agonist | |||
| 0.08 | 0.029 | 0.092 | NMDA receptor glycine site agonist | 0.092 0.02 CID_115260 | CID_115260 | |
| 0.143 | 0.092 | 0.143 | Melanin inhibitor | |||
| 0.109 | 0.059 | 0.369 | Expectorant | 0.369 0.005 CID_115260 | CID_115260 | |
| 0.061 | 0.012 | 0.061 | Geranyltranstransferase inhibitor | |||
| 0.092 | 0.044 | 0.092 | mTOR complex 2 inhibitor | |||
| 0.07 | 0.022 | 0.07 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.088 | 0.04 | 0.088 | Interferon agonist | |||
| 0.089 | 0.041 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.13 | 0.083 | 0.13 | Protein kinase stimulant | |||
| 0.082 | 0.036 | 0.082 | Sphingosine 1-phosphate receptor 4 agonist | 0.068 0.047 CID_115260 | ||
| 0.08 | 0.034 | 0.08 | Acetylcholine M5 receptor agonist | |||
| 0.169 | 0.124 | 0.169 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.134 | 0.089 | 0.134 | Pregnane X receptor agonist | |||
| 0.074 | 0.029 | 0.074 | MDM2 inhibitor | |||
| 0.048 | 0.003 | 0.048 | Complement factor 1r inhibitor | |||
| 0.074 | 0.03 | 0.074 | Interferon inducer | |||
| 0.1 | 0.056 | 0.1 | MAP kinase kinase 1 inhibitor | |||
| 0.075 | 0.031 | 0.075 | 5 Hydroxytryptamine 3 agonist | |||
| 0.073 | 0.029 | 0.136 | Carbonic anhydrase stimulant | 0.136 0.012 CID_115260 | CID_115260 | |
| 0.12 | 0.077 | 0.295 | Toll-Like receptor 2 antagonist | 0.295 0.005 CID_115260 | CID_115260 | |
| 0.066 | 0.025 | 0.066 | Sphingosine kinase 2 inhibitor | |||
| 0.093 | 0.052 | 0.099 | Ornithine decarboxylase inhibitor | 0.099 0.045 CID_115260 | CID_115260 | |
| 0.06 | 0.02 | 0.06 | Potassium channel (Inward rectifier) activator | |||
| 0.105 | 0.065 | 0.105 | Falcipain 3 inhibitor | |||
| 0.1 | 0.061 | 0.1 | Carbonic anhydrase III inhibitor | |||
| 0.056 | 0.017 | 0.056 | Histamine H2 receptor agonist | |||
| 0.047 | 0.009 | 0.047 | Uridine phosphorylase inhibitor | |||
| 0.112 | 0.073 | 0.112 | Cholesterol synthesis inhibitor | |||
| 0.051 | 0.013 | 0.051 | Heme oxygenase inhibitor | |||
| 0.087 | 0.049 | 0.087 | Carbonic anhydrase VI inhibitor | |||
| 0.057 | 0.019 | 0.057 | Potassium channel (ATP-sensitive) activator | |||
| 0.099 | 0.061 | 0.099 | Sphingomyelinase inhibitor | |||
| 0.052 | 0.015 | 0.052 | Histamine H1 receptor agonist | |||
| 0.059 | 0.022 | 0.059 | Adenosine deaminase inhibitor | 0.059 0.022 CID_115260 | ||
| 0.051 | 0.015 | 0.152 | Membrane dipeptidase inhibitor | 0.152 0.002 CID_115260 | CID_115260 | |
| 0.059 | 0.022 | 0.059 | Squalene epoxidase inhibitor | |||
| 0.06 | 0.024 | 0.06 | Immunoglobulin Fc receptor antagonist | |||
| 0.116 | 0.08 | 0.116 | DNA repair enzyme inhibitor | |||
| 0.056 | 0.02 | 0.056 | Dopamine beta hydroxylase inhibitor | |||
| 0.071 | 0.035 | 0.228 | NMDA receptor agonist | 0.228 0.004 CID_115260 | CID_115260 | |
| 0.041 | 0.006 | 0.041 | Purinergic P2Y15 antagonist | |||
| 0.067 | 0.035 | 0.067 | Transcription factor RelA inhibitor | |||
| 0.057 | 0.026 | 0.076 | Lysophosphatidic acid 3 receptor antagonist | 0.076 0.011 CID_115260 | CID_115260 | |
| 0.063 | 0.033 | 0.063 | Carbonic anhydrase VB inhibitor | |||
| 0.051 | 0.021 | 0.054 | AICAR transformylase inhibitor | 0.054 0.018 CID_115260 | CID_115260 | |
| 0.042 | 0.011 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.081 | 0.05 | 0.081 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.048 | 0.02 | 0.048 | Thymidine kinase inhibitor | |||
| 0.048 | 0.021 | 0.048 | Nerve growth factor antagonist | |||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | |||
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | |||
| 0.058 | 0.032 | 0.058 | Epithelial sodium channel blocker | |||
| 0.033 | 0.007 | 0.033 | Vanilloid 2 agonist | |||
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR3) antagonist | |||
| 0.065 | 0.04 | 0.065 | Calcium channel P-type blocker | |||
| 0.034 | 0.009 | 0.034 | Nicotinic acid receptor 2 antagonist | |||
| 0.048 | 0.023 | 0.048 | Glutamate (mGluR4) antagonist | 0.048 0.023 CID_115260 | ||
| 0.066 | 0.042 | 0.161 | Protease 3C (Human rhinovirus) inhibitor | 0.161 0.006 CID_115260 | CID_115260 | |
| 0.035 | 0.011 | 0.035 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.028 | 0.005 | 0.028 | Carbonic anhydrase X inhibitor | |||
| 0.028 | 0.005 | 0.028 | Carbonic anhydrase VIII inhibitor | |||
| 0.036 | 0.013 | 0.036 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.048 | 0.025 | 0.069 | Oxytocin agonist | 0.069 0.01 CID_115260 | CID_115260 | |
| 0.043 | 0.022 | 0.043 | GABA uptake inhibitor | |||
| 0.036 | 0.015 | 0.046 | Glutamate (mGluR3) agonist | 0.046 0.006 CID_115260 | CID_115260 | |
| 0.029 | 0.009 | 0.029 | Glutamate (mGluR1a) agonist | 0.026 0.011 CID_115260 | ||
| 0.031 | 0.011 | 0.031 | Hedgehog signaling activator | |||
| 0.111 | 0.091 | 0.111 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.03 | 0.012 | 0.03 | Thymidine phosphorylase inhibitor | |||
| 0.03 | 0.012 | 0.03 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.073 | 0.055 | 0.073 | Potassium channel (Tandem pore domain) blocker | |||
| 0.061 | 0.044 | 0.061 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.031 | 0.014 | 0.031 | Estrogen-related receptor gamma antagonist | |||
| 0.045 | 0.028 | 0.045 | Glutamate (mGluR group III) antagonist | |||
| 0.023 | 0.005 | 0.023 | Telomerase stimulant | |||
| 0.029 | 0.012 | 0.029 | Lysophosphatidic acid receptor 1 agonist | 0.027 0.014 CID_115260 | ||
| 0.09 | 0.074 | 0.09 | Bile acid receptor antagonist | |||
| 0.128 | 0.112 | 0.128 | MAP kinase 3 inhibitor | |||
| 0.024 | 0.008 | 0.024 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.028 | 0.012 | 0.028 | Acid ceramidase inhibitor | |||
| 0.031 | 0.016 | 0.031 | MAP3K8 inhibitor | |||
| 0.072 | 0.057 | 0.072 | Carbonic anhydrase XIII inhibitor | |||
| 0.038 | 0.024 | 0.18 | Arginase inhibitor | 0.18 0.002 CID_115260 | CID_115260 | |
| 0.021 | 0.007 | 0.021 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.048 | 0.034 | 0.048 | Cytokine production stimulant | |||
| 0.022 | 0.008 | 0.022 | Antibiotic Anthracycline-like | |||
| 0.028 | 0.016 | 0.028 | Glucosylceramidase stimulant | |||
| 0.054 | 0.042 | 0.054 | 5 Hydroxytryptamine 7 agonist | |||
| 0.034 | 0.022 | 0.034 | Melatonin receptor 1A agonist | |||
| 0.065 | 0.053 | 0.065 | Carbonic anhydrase VA inhibitor | |||
| 0.017 | 0.005 | 0.017 | Carbonic anhydrase XI inhibitor | |||
| 0.02 | 0.009 | 0.02 | Alpha 2a adrenoreceptor agonist | |||
| 0.024 | 0.013 | 0.024 | Isoleucine-tRNA ligase inhibitor | |||
| 0.098 | 0.086 | 0.212 | Adenylate cyclase inhibitor | 0.212 0.024 CID_115260 | CID_115260 | |
| 0.023 | 0.012 | 0.023 | Imidazoline I1 receptor antagonist | |||
| 0.019 | 0.008 | 0.019 | Purinergic P2Y1 agonist | |||
| 0.017 | 0.006 | 0.017 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.079 | 0.068 | 0.079 | Myeloperoxidase inhibitor | |||
| 0.057 | 0.047 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.038 | 0.028 | 0.038 | Vanilloid 3 antagonist | |||
| 0.089 | 0.079 | 0.094 | Urease inhibitor | 0.094 0.074 CID_115260 | CID_115260 | |
| 0.077 | 0.068 | 0.077 | Caspase 7 inhibitor | |||
| 0.099 | 0.089 | 0.099 | TRPA1 agonist | |||
| 0.015 | 0.006 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.031 | 0.022 | 0.031 | Potassium channel small-conductance Ca-activated activator | |||
| 0.028 | 0.021 | 0.028 | 5 Hydroxytryptamine 6 agonist | |||
| 0.044 | 0.036 | 0.044 | Purinergic P2X4 antagonist | |||
| 0.038 | 0.03 | 0.038 | Dihydropteroate synthase inhibitor | |||
| 0.017 | 0.009 | 0.017 | Thromboxane A2 agonist | |||
| 0.05 | 0.043 | 0.05 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.055 | 0.048 | 0.055 | Sphingosine kinase inhibitor | |||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | 0.011 0.009 CID_115260 | ||
| 0.031 | 0.024 | 0.031 | ATP citrate lysase inhibitor | |||
| 0.033 | 0.026 | 0.033 | Retinoid X alpha receptor agonist | |||
| 0.026 | 0.019 | 0.115 | Lysine carboxypeptidase inhibitor | 0.115 0.003 CID_115260 | CID_115260 | |
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.056 | 0.051 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.075 | 0.07 | 0.576 | Glutathione S-transferase inhibitor | 0.576 0.001 CID_115260 | CID_115260 | |
| 0.036 | 0.03 | 0.036 | Potassium channel Kv1.1 blocker | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | |||
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.163 | 0.158 | 0.298 | Calpain inhibitor | 0.298 0.031 CID_115260 | CID_115260 | |
| 0.037 | 0.032 | 0.109 | AMPA 4 receptor antagonist | 0.109 0.005 CID_115260 | CID_115260 | |
| 0.042 | 0.038 | 0.096 | Thymidylate synthase inhibitor | 0.096 0.005 CID_115260 | CID_115260 | |
| 0.037 | 0.033 | 0.037 | 5 Hydroxytryptamine 2B agonist | |||
| 0.038 | 0.035 | 0.038 | CF transmembrane conductance regulator antagonist | |||
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | |||
| 0.112 | 0.109 | 0.112 | Nav1.6 sodium channel blocker | |||
| 0.021 | 0.018 | 0.021 | Prostaglandin F2 alpha agonist | |||
| 0.013 | 0.01 | 0.013 | Cyclin D2 inhibitor | |||
| 0.031 | 0.029 | 0.031 | Protein kinase (CK2) beta inhibitor | |||
| 0.058 | 0.056 | 0.058 | Carbonic anhydrase V inhibitor | |||
| 0.016 | 0.014 | 0.016 | Nicotinic acid receptor 1 antagonist | |||
| 0.028 | 0.027 | 0.028 | Epoxide hydrolase 1 inhibitor | |||
| 0.023 | 0.022 | 0.024 | Glutamate (mGluR1) agonist | 0.024 0.019 CID_115260 | CID_115260 | |
| 0.057 | 0.056 | 0.057 | Phosphodiesterase 1C inhibitor | |||
| 0.04 | 0.039 | 0.04 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.049 | 0.048 | 0.049 | Heparanase inhibitor | |||
| 0.01 | 0.009 | 0.01 | Purinergic P2Y2 agonist | |||
| 0.044 | 0.046 | 0.062 | Prolyl endopeptidase inhibitor | 0.062 0.022 CID_115260 | CID_115260 | |
| 0.028 | 0.031 | 0.034 | Dipeptidyl peptidase II inhibitor | 0.034 0.02 CID_115260 | CID_115260 | |
| 0.033 | 0.037 | 0.327 | Toll-Like receptor 2 agonist | 0.327 0.002 CID_115260 | CID_115260 | |
| 0.027 | 0.031 | 0.063 | Calcitonin receptor agonist | 0.063 0.014 CID_115260 | CID_115260 | |
| 0.172 | 0.178 | 0.254 | Neuropeptide Y2 antagonist | 0.254 0.052 CID_115260 | CID_115260 | |
| 0.056 | 0.063 | 0.091 | Histone deacetylase SIRT3 inhibitor | 0.091 0.013 CID_115260 | CID_115260 | |
| 0.012 | 0.02 | 0.132 | Aminopeptidase A inhibitor | 0.132 0.002 CID_115260 | CID_115260 | |
| 0.051 | 0.06 | 0.085 | NMDA 2C receptor antagonist | 0.085 0.022 CID_115260 | CID_115260 | |
| 0.026 | 0.035 | 0.043 | Methionyl aminopeptidase 1 inhibitor | 0.043 0.009 CID_115260 | CID_115260 | |
| 0.042 | 0.051 | 0.124 | Bombesin 2 receptor antagonist | 0.124 0.012 CID_115260 | CID_115260 | |
| 0.09 | 0.101 | 0.287 | Alkylator | 0.287 0.013 CID_115260 | CID_115260 | |
| 0.041 | 0.054 | 0.087 | HCV NS3/NS4A protease inhibitor | 0.087 0.008 CID_115260 | CID_115260 | |
| 0.027 | 0.041 | 0.046 | Carboxypeptidase B inhibitor | 0.046 0.008 CID_115260 | CID_115260 | |
| 0.024 | 0.038 | 0.052 | Kainate receptor 2 antagonist | 0.052 0.015 CID_115260 | CID_115260 | |
| 0.022 | 0.037 | 0.072 | Peptide deformylase inhibitor | 0.072 0.005 CID_115260 | CID_115260 | |
| 0.115 | 0.13 | 0.382 | Thiol protease inhibitor | 0.382 0.014 CID_115260 | CID_115260 | |
| 0.058 | 0.074 | 0.077 | Cathepsin G inhibitor | 0.077 0.046 CID_115260 | CID_115260 | |
| 0.047 | 0.064 | 0.127 | Botulinum neurotoxin type A inhibitor | 0.127 0.006 CID_115260 | CID_115260 | |
| 0.03 | 0.047 | 0.042 | Carbonic anhydrase IV inhibitor | 0.042 0.03 CID_115260 | CID_115260 | |
| 0.09 | 0.109 | 0.204 | Caspase 3 inhibitor | 0.204 0.009 CID_115260 | CID_115260 | |
| 0.033 | 0.053 | 0.128 | Antimetabolite | 0.128 0.013 CID_115260 | CID_115260 | |
| 0.025 | 0.047 | 0.034 | Melanocortin 1 antagonist | 0.034 0.031 CID_115260 | CID_115260 | |
| 0.014 | 0.036 | 0.02 | Caspase 8 inhibitor | 0.02 0.012 CID_115260 | CID_115260 | |
| 0.011 | 0.033 | 0.045 | Neurokinin 1 agonist | 0.045 0.007 CID_115260 | CID_115260 | |
| 0.008 | 0.034 | 0.019 | Integrin alphaVbeta6 antagonist | 0.019 0.006 CID_115260 | CID_115260 | |
| 0.138 | 0.166 | 0.664 | Immunostimulant | 0.664 0.01 CID_115260 | CID_115260 | |
| 0.032 | 0.06 | 0.142 | Ribonucleoside-diphosphate reductase inhibitor | 0.142 0.012 CID_115260 | CID_115260 | |
| 0.032 | 0.061 | 0.138 | Ribonucleotide reductase inhibitor | 0.138 0.014 CID_115260 | CID_115260 | |
| 0.008 | 0.039 | 0.08 | Ileal bile acid transport inhibitor | 0.08 0.002 CID_115260 | CID_115260 | |
| 0.04 | 0.071 | 0.068 | CD45 antagonist | 0.068 0.016 CID_115260 | CID_115260 | |
| 0.023 | 0.055 | 0.097 | Kainate receptor antagonist | 0.097 0.008 CID_115260 | CID_115260 | |
| 0.013 | 0.046 | 0.046 | Geranylgeranyltransferase inhibitor | 0.046 0.005 CID_115260 | CID_115260 | |
| 0.017 | 0.053 | 0.037 | Endothelial nitric-oxide synthase inhibitor | 0.037 0.016 CID_115260 | CID_115260 | |
| 0.014 | 0.05 | 0.039 | AMPA 3 receptor antagonist | 0.039 0.014 CID_115260 | CID_115260 | |
| 0.174 | 0.214 | 0.459 | Antithrombotic | 0.459 0.036 CID_115260 | CID_115260 | |
| 0.072 | 0.114 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | 0.11 0.045 CID_115260 | CID_115260 | |
| 0.113 | 0.155 | 0.177 | Psychostimulant | 0.177 0.095 CID_115260 | CID_115260 | |
| 0.026 | 0.069 | 0.128 | NMDA 2A receptor antagonist | 0.128 0.009 CID_115260 | CID_115260 | |
| 0.125 | 0.168 | 0.346 | Insulin sensitizer | 0.346 0.009 CID_115260 | CID_115260 | |
| 0.109 | 0.153 | 0.128 | Neuropeptide Y1 antagonist | 0.128 0.105 CID_115260 | CID_115260 | |
| 0.05 | 0.106 | 0.083 | Secretase beta inhibitor | 0.083 0.032 CID_115260 | CID_115260 | |
| 0.021 | 0.076 | 0.097 | Factor XIIIa inhibitor | 0.097 0.006 CID_115260 | CID_115260 | |
| 0.058 | 0.116 | 0.241 | Inducible nitric-oxide synthase inhibitor | 0.241 0.005 CID_115260 | CID_115260 | |
| 0.03 | 0.089 | 0.104 | Cathepsin L inhibitor | 0.104 0.02 CID_115260 | CID_115260 | |
| 0.016 | 0.076 | 0.044 | Cathepsin L1 inhibitor | 0.044 0.023 CID_115260 | CID_115260 | |
| 0.006 | 0.066 | 0.092 | AMPA 1 receptor antagonist | 0.092 0.006 CID_115260 | CID_115260 | |
| 0.013 | 0.073 | 0.033 | Sirtuin 2 inhibitor | 0.033 0.023 CID_115260 | CID_115260 | |
| 0.015 | 0.076 | 0.088 | Calcium-sensing receptor agonist | 0.088 0.004 CID_115260 | CID_115260 | |
| 0.083 | 0.149 | 0.121 | Interleukin 8 antagonist | 0.121 0.06 CID_115260 | CID_115260 | |
| 0.07 | 0.138 | 0.214 | Proteasome inhibitor | 0.214 0.021 CID_115260 | CID_115260 | |
| 0.066 | 0.135 | 0.272 | Nitric-oxide synthase inhibitor | 0.272 0.005 CID_115260 | CID_115260 | |
| 0.031 | 0.102 | 0.238 | Neutrophil collagenase inhibitor | 0.238 0.006 CID_115260 | CID_115260 | |
| 0.025 | 0.101 | 0.052 | Plasmepsin II inhibitor | 0.052 0.016 CID_115260 | CID_115260 | |
| 0.023 | 0.099 | 0.1 | Metalloproteinase-3 inhibitor | 0.1 0.01 CID_115260 | CID_115260 | |
| 0.149 | 0.228 | 0.383 | Transcription factor NF kappa B inhibitor | 0.383 0.067 CID_115260 | CID_115260 | |
| 0.047 | 0.131 | 0.164 | Metalloproteinase-9 inhibitor | 0.164 0.013 CID_115260 | CID_115260 | |
| 0.028 | 0.12 | 0.095 | Matrix metalloproteinase (membrane-type) inhibitor | 0.095 0.015 CID_115260 | CID_115260 | |
| 0.085 | 0.181 | 0.345 | Phospholipase A2 inhibitor | 0.345 0.008 CID_115260 | CID_115260 | |
| 0.02 | 0.115 | 0.088 | Matrix metalloproteinase 1 inhibitor | 0.088 0.018 CID_115260 | CID_115260 | |
| 0.148 | 0.245 | 0.211 | Transcription factor STAT inhibitor | 0.211 0.122 CID_115260 | CID_115260 | |
| 0.017 | 0.118 | 0.405 | Glycine transporter 2 inhibitor | 0.405 0.003 CID_115260 | CID_115260 | |
| 0.097 | 0.201 | 0.35 | DNA methylase inhibitor | 0.35 0.017 CID_115260 | CID_115260 | |
| 0.093 | 0.197 | 0.322 | DNA methyltransferase I inhibitor | 0.322 0.019 CID_115260 | CID_115260 | |
| 0.029 | 0.14 | 0.163 | Matrix metalloproteinase inhibitor | 0.163 0.012 CID_115260 | CID_115260 | |
| 0.04 | 0.151 | 0.171 | Metalloproteinase-2 inhibitor | 0.171 0.014 CID_115260 | CID_115260 | |
| 0.003 | 0.116 | 0.017 | Integrin alpha4beta1 antagonist | 0.017 0.011 CID_115260 | CID_115260 | |
| 0.132 | 0.245 | 0.256 | Transcription factor STAT3 inhibitor | 0.256 0.078 CID_115260 | CID_115260 | |
| 0.136 | 0.257 | 0.389 | Calpain 2 inhibitor | 0.389 0.067 CID_115260 | CID_115260 | |
| 0.088 | 0.216 | 0.206 | Hemostatic | 0.206 0.03 CID_115260 | CID_115260 | |
| 0.076 | 0.208 | 0.329 | Diuretic | 0.329 0.018 CID_115260 | CID_115260 | |
| 0.095 | 0.229 | 0.137 | Non-steroidal antiinflammatory agent | 0.137 0.136 CID_115260 | CID_115260 | |
| 0.003 | 0.167 | 0.036 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.036 0.004 CID_115260 | CID_115260 | |
| 0.023 | 0.291 | 0.072 | Carbonic anhydrase II stimulant | 0.072 0.013 CID_115260 | CID_115260 | |
| 0.054 | 0.356 | 0.303 | Antiamyloidogenic | 0.303 0.051 CID_115260 | CID_115260 | |
| 0.025 | 0.336 | 0.107 | Somatostatin 1 agonist | 0.107 0.03 CID_115260 | CID_115260 | |
| 0.094 | 0.411 | 0.34 | Antibacterial | 0.34 0.108 CID_115260 | CID_115260 | |
| 0.087 | 0.432 | 0.458 | Sodium/bile acid cotransporter inhibitor | 0.458 0.007 CID_115260 | CID_115260 | |
| 0.01 | 0.372 | 0.054 | Growth hormone release inhibitor | 0.054 0.019 CID_115260 | CID_115260 | |
| 0.007 | 0.477 | 0.069 | Carbonic anhydrase I stimulant | 0.069 0.009 CID_115260 | CID_115260 | |
| 0.001 | 0.795 | 0.032 | Human T-cell leukemia virus type I protease inhibitor | 0.032 0.007 CID_115260 | CID_115260 | |
| 0.005 | 0.829 | 0.213 | Aminoacyl-tRNA synthetase inhibitor | 0.213 0.01 CID_115260 | CID_115260 | |
| 0.011 | 0.842 | 0.066 | Vanilloid 2 antagonist | 0.066 0.017 CID_115260 | CID_115260 | |
| 0.01 | 0.878 | 0.049 | Integrin alpha1beta1 antagonist | 0.049 0.008 CID_115260 | CID_115260 | |
| 0.002 | 0.982 | 0.038 | Melanocortin 4 antagonist | 0.038 0.033 CID_115260 | CID_115260 | |
| 0.005 | 0.99 | 0.032 | HCV polyprotein inhibitor | 0.032 0.031 CID_115260 | CID_115260 | |
| 0.004 | 0.99 | 0.529 | Angiogenesis stimulant | 0.529 0.01 CID_115260 | CID_115260 | |
| 0.012 | 0.998 | 0.343 | Peptidyltransferase inhibitor | 0.343 0.013 CID_115260 | CID_115260 | |
| 0 | 0.991 | 0.033 | Aminopeptidase P inhibitor | 0.033 0.008 CID_115260 | CID_115260 | |
| 0.004 | 0.996 | 0.057 | Kallikrein 1 inhibitor | 0.057 0.038 CID_115260 | CID_115260 | |
| 0.003 | 0.996 | 0.111 | Chymotrypsin inhibitor | 0.111 0.029 CID_115260 | CID_115260 | |
| 0.003 | 0.996 | 0.093 | Vanilloid agonist | 0.093 0.043 CID_115260 | CID_115260 | |
| 0.005 | 0.998 | 0.389 | Interleukin 2 agonist | 0.389 0.031 CID_115260 | CID_115260 | |
| 0.002 | 0.995 | 0.109 | Endothelin-converting enzyme inhibitor | 0.109 0.013 CID_115260 | CID_115260 | |
| 0.003 | 0.996 | 0.161 | Amyloid beta aggregation inhibitor | 0.161 0.1 CID_115260 | CID_115260 | |
| 0.002 | 0.996 | 0.107 | Cathepsin B inhibitor | 0.107 0.014 CID_115260 | CID_115260 | |
| 0.001 | 0.995 | 0.033 | Calpain 1 inhibitor | 0.033 0.025 CID_115260 | CID_115260 | |
| 0.002 | 0.996 | 0.174 | Sirtuin 1 inhibitor | 0.174 0.005 CID_115260 | CID_115260 | |
| 0.001 | 0.996 | 0.043 | AMPA 2 receptor antagonist | 0.043 0.013 CID_115260 | CID_115260 | |
| 0.001 | 0.996 | 0.066 | Collagenase inhibitor | 0.066 0.011 CID_115260 | CID_115260 | |
| 0.002 | 0.997 | 0.037 | Glucagon-like peptide 1 receptor antagonist | 0.037 0.034 CID_115260 | CID_115260 | |
| 0.004 | 0.998 | 0.168 | Factor V inhibitor | 0.168 0.012 CID_115260 | CID_115260 | |
| 0.002 | 0.997 | 0.054 | Glutamate (mGluR8) antagonist | 0.054 0.007 CID_115260 | CID_115260 | |
| 0.002 | 0.996 | 0.052 | Plasminogen activator inhibitor | 0.052 0.046 CID_115260 | CID_115260 | |
| 0.001 | 0.996 | 0.175 | Selectin antagonist | 0.175 0.014 CID_115260 | CID_115260 | |
| 0.001 | 0.996 | 0.252 | Leukotriene A4 hydrolase inhibitor | 0.252 0.004 CID_115260 | CID_115260 | |
| 0.002 | 0.997 | 0.343 | Chelator | 0.343 0.008 CID_115260 | CID_115260 | |
| 0.002 | 0.997 | 0.077 | Neuropeptide agonist | 0.077 0.032 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.032 | AMPA receptor agonist | 0.032 0.031 CID_115260 | CID_115260 | |
| 0.003 | 0.999 | 0.499 | Growth hormone agonist | 0.499 0.006 CID_115260 | CID_115260 | |
| 0.002 | 0.997 | 0.143 | Protein-tyrosine phosphatase inhibitor | 0.143 0.087 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.02 | Integrin alphaVbeta3 antagonist | 0.02 0.018 CID_115260 | CID_115260 | |
| 0.002 | 0.998 | 0.107 | Adenine nucleotide translocase inhibitor | 0.107 0.004 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.133 | Aminopeptidase N inhibitor | 0.133 0.007 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.154 | Aminopeptidase microsomal inhibitor | 0.154 0.007 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.022 | Vitronectin receptor antagonist | 0.022 0.014 CID_115260 | CID_115260 | |
| 0.002 | 0.998 | 0.385 | Hepatoprotectant | 0.385 0.015 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.177 | Protease inhibitor | 0.177 0.02 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.068 | Macrophage elastase inhibitor | 0.068 0.015 CID_115260 | CID_115260 | |
| 0.002 | 0.998 | 0.218 | Nav1.4 sodium channel blocker | 0.218 0.015 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.072 | Cholecystokinin B antagonist | 0.072 0.006 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.098 | Cholecystokinin A antagonist | 0.098 0.009 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.026 | Geranylgeranyltransferase I inhibitor | 0.026 0.011 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.042 | VCAM-1 antagonist | 0.042 0.02 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.042 | VCAM antagonist | 0.042 0.02 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.102 | Cholecystokinin antagonist | 0.102 0.008 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.124 | Neurokinin 2 agonist | 0.124 0.004 CID_115260 | CID_115260 | |
| 0.001 | 0.997 | 0.116 | Opioid delta receptor antagonist | 0.116 0.027 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.07 | Trypsin inhibitor | 0.07 0.033 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.181 | Angiotensin-converting enzyme inhibitor | 0.181 0.004 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.217 | Vasodilator | 0.217 0.091 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.235 | Apoptosis agonist | 0.235 0.231 CID_115260 | CID_115260 | |
| 0.002 | 0.999 | 0.139 | Transcription factor NF kappa B stimulant | 0.139 0.018 CID_115260 | CID_115260 | |
| 0.002 | 0.999 | 0.181 | Folate antagonist | 0.181 0.014 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.24 | Histone deacetylase class III inhibitor | 0.24 0.01 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.139 | Factor XII inhibitor | 0.139 0.016 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.107 | Opioid mu receptor antagonist | 0.107 0.029 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.448 | Apoptosis antagonist | 0.448 0.028 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.254 | Free radical scavenger | 0.254 0.067 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.127 | Opioid antagonist | 0.127 0.033 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.101 | Analgesic, opioid | 0.101 0.03 CID_115260 | CID_115260 | |
| 0 | 0.997 | 0.017 | Carbonic anhydrase IV stimulant | 0.017 0.009 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.1 | Cathepsin D inhibitor | 0.1 0.019 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.033 | Opioid delta receptor agonist | 0.033 0.029 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.147 | Lipid peroxidase inhibitor | 0.147 0.07 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.091 | Thrombin inhibitor | 0.091 0.032 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.05 | Opioid mu receptor agonist | 0.05 0.029 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.068 | Cathepsin F inhibitor | 0.068 0.004 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.189 | Platelet adhesion inhibitor | 0.189 0.077 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.198 | Bone formation stimulant | 0.198 0.036 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.035 | Trypsin I inhibitor | 0.035 0.021 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.057 | VLA-4 antagonist | 0.057 0.011 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.02 | Neurokinin 3 agonist | 0.02 0.004 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.077 | Protocollagen prolyl hydroxylase inhibitor | 0.077 0.005 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.075 | Kinesin antagonist | 0.075 0.011 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.075 | Kinesin-like protein 1 inhibitor | 0.075 0.011 CID_115260 | CID_115260 | |
| 0.001 | 0.998 | 0.132 | Farnesyltransferase inhibitor | 0.132 0.005 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.079 | Caspase 9 inhibitor | 0.079 0.024 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.038 | Caspase 2 inhibitor | 0.038 0.017 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.164 | Bombesin 1 receptor agonist | 0.164 0.007 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.275 | Antioxidant | 0.275 0.072 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.636 | Interleukin antagonist | 0.636 0.009 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.134 | Integrin antagonist | 0.134 0.012 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.22 | Hypoglycemic | 0.22 0.096 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.048 | Parathyroid hormone antagonist | 0.048 0.026 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.379 | Anticoagulant | 0.379 0.018 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.264 | Immunosuppressant | 0.264 0.138 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.041 | Bombesin 1 receptor antagonist | 0.041 0.021 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.044 | HIV-1 protease inhibitor | 0.044 0.028 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.018 | Angiotensin-converting enzyme 2 inhibitor | 0.018 0.011 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.583 | Immunomodulator | 0.583 0.013 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.038 | Growth factor receptor-bound protein 2 antagonist | 0.038 0.017 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.182 | Cell adhesion inhibitor | 0.182 0.03 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.086 | Neutral endopeptidase inhibitor | 0.086 0.005 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.082 | Complement C3a chemotactic receptor antagonist | 0.082 0.013 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.066 | Cathepsin E inhibitor | 0.066 0.034 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.149 | Cholecystokinin B agonist | 0.149 0.005 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.043 | Integrin alpha4 antagonist | 0.043 0.013 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.503 | Hematopoietic | 0.503 0.004 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.226 | Tumour necrosis factor alpha release inhibitor | 0.226 0.089 CID_115260 | CID_115260 | |
| 0 | 0.998 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.007 0.006 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.448 | Erythropoietin receptor agonist | 0.448 0.004 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.14 | GP IIb/IIIa receptor antagonist | 0.14 0.012 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.473 | Thrombolytic | 0.473 0.006 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.147 | Glucagon-like peptide 1 agonist | 0.147 0.009 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.081 | Human rhinovirus A protease inhibitor | 0.081 0.023 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.075 | Neurotensin receptor antagonist | 0.075 0.019 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.443 | Platelet antagonist | 0.443 0.02 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.03 | Growth hormone releasing factor antagonist | 0.03 0.013 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.329 | Histone deacetylase SIRT1 inhibitor | 0.329 0.005 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.043 | Bradykinin B2 receptor agonist | 0.043 0.01 CID_115260 | CID_115260 | |
| 0.001 | 0.999 | 0.07 | Gonadotropin-releasing hormone receptor agonist | 0.07 0.026 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.009 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.064 | Bombesin antagonist | 0.064 0.016 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.093 | Histone deacetylase SIRT2 inhibitor | 0.093 0.035 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.099 | Nitric oxide donor | 0.099 0.009 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.024 | Cholecystokinin A agonist | 0.024 0.007 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.054 | Renin inhibitor | 0.054 0.015 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.051 | Cholecystokinin agonist | 0.051 0.007 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.019 | Integrin beta7 antagonist | 0.019 0.015 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.201 | Insulin secretagoues | 0.201 0.035 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.061 | Integrin alpha5beta1 antagonist | 0.061 0.011 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.032 | Glucagon agonist | 0.032 0.006 CID_115260 | CID_115260 | |
| 0 | 0.999 | 0.105 | Cell adhesion molecule inhibitor | 0.105 0.031 CID_115260 | CID_115260 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |